Design of the silent cerebral infarct transfusion (SIT) trial.
about
Interventions for preventing silent cerebral infarcts in people with sickle cell diseaseInterventions for preventing silent cerebral infarcts in people with sickle cell diseaseBlood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseSickle cell disease in childrenSilent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemiaProteomic and biomarker studies and neurological complications of pediatric sickle cell diseaseClinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trialStroke in patients with sickle cell disease.Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.How I manage cerebral vasculopathy in children with sickle cell disease.Magnetic resonance imaging in pediatric sickle cell anemia.Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.Randomization is not associated with socio-economic and demographic factors in a multi-center clinical trial of children with sickle cell anemiaGenome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseSilent cerebral infarction, income, and grade retention among students with sickle cell anemia.Genome-wide meta-analysis of systolic blood pressure in children with sickle cell diseaseHealth-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity.Parent education and biologic factors influence on cognition in sickle cell anemiaIncidental findings on brain magnetic resonance imaging of children with sickle cell disease.Hemoglobin depletion from plasma: considerations for proteomic discovery in sickle cell disease and other hemolytic processes.Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia.Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia.Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease.Prospects for primary stroke prevention in children with sickle cell anaemiaBlood transfusion for preventing primary and secondary stroke in people with sickle cell disease.Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease.Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell diseaseInterventions for preventing silent cerebral infarcts in people with sickle cell disease.Developmental function in toddlers with sickle cell anemia.Acute silent cerebral ischemic events in children with sickle cell anemia.Extent of silent cerebral infarcts in adult sickle-cell disease patients on magnetic resonance imaging: is there a correlation with the clinical severity of disease?Nocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemiaPartial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia
P2860
Q24186853-C261761E-FEFE-40F1-B606-8C4BA76291C0Q24200712-E91FB47B-B0C0-4312-AE5A-461738CDD81FQ24202463-448F0FD4-9B1E-42EE-AB95-63124155580DQ26864582-08CD0317-71F0-442F-AD60-1CFBC30515D6Q27026479-EB98081C-1604-4373-B603-71C6A8FE9C44Q27027066-F2BAFA13-F8DC-4A4F-9298-5F77002ACD18Q30536320-26E37626-632F-4C2B-BEA2-C035EB77E8E4Q30650303-5AEE0385-BF9E-480E-8CE9-B3B0F398D3DFQ30757538-7239D806-CCFA-4326-9D6A-64EAC171C4ECQ30945117-262762C6-C83C-4EE9-B476-140F83D590F3Q31116644-873FD5C5-2D0F-48C8-ADFA-156E8287C409Q33631906-A5C46FF5-1F0D-4A18-806D-07A3F537678CQ33919537-C0606971-C895-442B-840F-B7FF899D6F38Q33934737-127BA10D-2493-4F53-A00F-99FFEF703AE6Q34165031-A2A5E122-359C-410F-9B0B-D12432940107Q34330904-ACB11BA9-000F-4398-8D7B-4ACB2FB9EE56Q34557931-F4381443-665D-43D6-8D8D-B5CC449B6C12Q34665167-B9CD650D-70F5-4E31-999F-01DFC737F64EQ34994543-BEDD1736-2691-48D3-990C-645849570508Q35007607-FEF485FA-FC76-4E91-914B-B52E3E1715E4Q35017163-0C510421-8BAC-4E6D-AF95-E2AFB9698326Q35026922-D229FF3C-D506-4104-9193-91380C6822ABQ35157521-D6A44421-88C5-490F-817E-A40B84A9C975Q35190564-586A3AB4-5569-4134-AFFB-8F69F0984E61Q35291871-E6C67232-808A-4074-AC78-0D9F71F9F44EQ35339935-4495D84F-5CFB-4849-893E-FD4722069B43Q35909642-39C0C1E5-65F2-4CAA-AA27-B98B0D9B8108Q36034663-F5E356BB-5B2D-44ED-8B8F-C713695F7121Q36105129-858EB5DB-3FC8-4E21-B584-EE907F1E4A70Q36251052-FE2B14D9-7D4A-4DFD-A9BE-5BA90EAED416Q36349336-DC50EF6B-FAD8-43F3-BDC2-0A59E1681A18Q36370871-64868887-851D-411C-89A4-81C29527CAD0Q36370980-F34F466A-1C6B-4356-B226-DC6CB506114DQ36568784-61BF2A77-313D-47DB-922B-5BED11C2E949Q36914931-BC80FCAF-67BC-45C8-8CE1-6C2339CA0C7AQ37034611-7170F70A-7027-4B01-8F9A-FDB590A697B1Q37059565-C5B01E16-E665-46AA-80F5-905BBAF83BC4Q37122576-733CD0D3-8D3F-4C9A-B283-4857DE19AEBAQ37178468-DAE83A28-27B2-414B-A167-9D5C8E77BA7EQ37238159-D974A08D-B2BD-4DD1-9263-34E8D89A701E
P2860
Design of the silent cerebral infarct transfusion (SIT) trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Design of the silent cerebral infarct transfusion (SIT) trial.
@en
type
label
Design of the silent cerebral infarct transfusion (SIT) trial.
@en
prefLabel
Design of the silent cerebral infarct transfusion (SIT) trial.
@en
P2093
P2860
P50
P1476
Design of the silent cerebral infarct transfusion (SIT) trial
@en
P2093
Bruce A Vendt
Caterina P Minniti
Cindy Terrill
Deborah Hirtz
Desiree A White
James F Casella
John J Strouse
Michael J Noetzel
Michael R Debaun
Rebecca N Ichord
P2860
P356
10.3109/08880010903360367
P577
2010-03-01T00:00:00Z